For instance, PPARγ agonists, such as thiazolidinediones (TZDs) like pioglitazone and rosiglitazone, have shown efficacy in improving insulin sensitivity in T2DM [21]. The gene discussed is INS; the disease is type 2 diabetes mellitus.